14.01.2021 • NewsTechnip

TechnipFMC Resumes Separation Plans

TechnipFMC has restarted plans to split into two publicly traded companies: TechnipFMC and Technip Energies. The group put the separation plans on hold last March because of the coronavirus pandemic and turbulent financial markets.

“The increased clarity we now have in the market outlook coupled with our demonstrated ability to successfully execute projects in this most challenging period give us confidence to move forward with the separation. We continue to believe this action would allow both businesses to thrive independently within their sectors, enabling each to unlock significant shareholder value,” said Doug Pferdehirt, TechnipFMC’s chairman and CEO.

The transaction is expected to be structured as a spin-off of a majority stake in Technip Energies. TechnipFMC will distribute 50.1% of the shares in Technip Energies to existing TechnipFMC shareholders on a pro rata basis. TechnipFMC will retain ownership of the remaining 49.9% of Technip Energies’ shares.

Bpifrance, a major shareholder of TechnipFMC, is supporting the move and intends to invest $200 million in Technip Energies by acquiring shares from TechnipFMC’s retained stake in Technip Energies.

TechnipFMC said the separation will enhance both companies’ focus on their respective strategies and provide improved flexibility and growth opportunities. Pferdehirt will remain as chairman and CEO of TechnipFMC, which will remain incorporated in the UK with headquarters in Houston, Texas, USA.

TechnipEnergies will have leadership positions in LNG, hydrogen and ethylene and growing market positions in sustainable chemistry and CO2 management. It will be incorporated in the Netherlands with its headquarters in Paris, France. Arnaud Pieton, currently president of Technip Energies, will become CEO.

The transaction is expected to complete in the first quarter of 2021.

Author: Elaine Burridge, Freelance Journalist

TechnipFMC has restarted plans to split into two publicly traded companies:...
TechnipFMC has restarted plans to split into two publicly traded companies: TechnipFMC and Technip Energies. The group put the separation plans on hold last March because of the coronavirus pandemic and turbulent financial markets. The transaction is expected to complete in Q1. (c) Technip

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.